Suppression of tumour necrosis factor-α by Schizonepeta tenuifolia water extract via inhibition of IκBα degradation and Jun N-terminal kinase/stress-activated protein kinase activation
Hee Kang
Department of East-West Medical Science, Graduate School of East-West Medical Science, Kyung Hee University, Yongin-si, Gyeonggi-do, South Korea
Search for more papers by this authorSang-Woo Han
Department of East-West Medical Science, Graduate School of East-West Medical Science, Kyung Hee University, Yongin-si, Gyeonggi-do, South Korea
Search for more papers by this authorJoung-Woo Hong
Department of East-West Medical Science, Graduate School of East-West Medical Science, Kyung Hee University, Yongin-si, Gyeonggi-do, South Korea
Search for more papers by this authorNak-Won Sohn
Department of East-West Medical Science, Graduate School of East-West Medical Science, Kyung Hee University, Yongin-si, Gyeonggi-do, South Korea
Search for more papers by this authorHee Kang
Department of East-West Medical Science, Graduate School of East-West Medical Science, Kyung Hee University, Yongin-si, Gyeonggi-do, South Korea
Search for more papers by this authorSang-Woo Han
Department of East-West Medical Science, Graduate School of East-West Medical Science, Kyung Hee University, Yongin-si, Gyeonggi-do, South Korea
Search for more papers by this authorJoung-Woo Hong
Department of East-West Medical Science, Graduate School of East-West Medical Science, Kyung Hee University, Yongin-si, Gyeonggi-do, South Korea
Search for more papers by this authorNak-Won Sohn
Department of East-West Medical Science, Graduate School of East-West Medical Science, Kyung Hee University, Yongin-si, Gyeonggi-do, South Korea
Search for more papers by this authorAbstract
Objectives The anti-inflammatory effects of an aqueous extract of Schizonepeta tenuifolia on lipopolysaccharide (LPS)-induced tumour necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in vivo and in vitro have been investigated.
Methods C57BL/6 mice were orally administered phosphate-buffered saline (control) or S. tenuifolia water extract (50, 200, 500 or 1000 mg/kg) for 10 days before intraperitoneal administration of LPS (1.3 mg/kg). Blood samples were obtained 1 h after LPS challenge, followed by determination of TNF-α and IL-6 levels. Peritoneal macrophages from thioglycollate-injected mice were obtained and stimulated with LPS and S. tenuifolia water extract for viability assay, cytokine analysis, real-time RT PCR and Western blotting.
Key findings Oral administration of S. tenuifolia water extract to mice significantly reduced LPS-induced serum levels of TNF-α, but not IL-6. When peritoneal macrophages were treated in vitro with S. tenuifolia water extract, the inhibition of LPS-induced TNF-α was more pronounced than that of IL-6 at the level of secreted protein and mRNA. S. tenuifolia water extract reduced the degradation of IκBα and the nuclear relocation of p65 NF-κB, but the phosphorylation of IκBα was not affected. Inhibition of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) by S. tenuifolia water extract led secondarily to the inhibition of phospho-c-Jun and phospho-ATF-2.
Conclusions These results indicated that the downregulation of TNF-α by S. tenuifolia water extract may have involved the inhibition of both IκBα degradation and activation of c-Jun and ATF-2 involving suppression of JNK/SAPK.
References
- 1 D'Acquisto F et al. Inhibition of nuclear factor kappa B (NF-B): an emerging theme in anti-inflammatory therapies. Mol Interv 2002; 2: 22–35.
- 2 Ramadori G et al. Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha. Eur J Immunol 1988; 18: 1259–1264.
- 3 Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995; 270: 16483–16486.
- 4 Geppert TD et al. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway. Mol Med 1994; 1: 93–103.
- 5 Lee JC et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994; 372: 739–746.
- 6 Swantek JL et al. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK. Mol Cell Biol 1997; 17: 6274–6282.
- 7 Fung D, Lau CB. Schizonepeta tenuifolia: chemistry, pharmacology, and clinical applications. J Clin Pharmacol 2002; 42: 30–36.
- 8 Shin TY et al. Effect of Schizonepeta tenuifolia extract on mast cell-mediated immediate-type hypersensitivity in rats. Immunopharmacol Immunotoxicol 1999; 21: 705–715.
- 9 Kang H et al. Immunomodulatory effect of Schizonepeta tenuifolia water extract on mouse Th1/Th2 cytokine production in-vivo and in-vitro. J Pharm Pharmacol 2008; 60: 901–907.
- 10 Kim SJ et al. Anti-inflammatory activity of Schizonepeta tenuifolia through the inhibition of MAPK phosphorylation in mouse peritoneal macrophages. Am J Chin Med 2008; 36: 1145–1158.
- 11 Elias JA, Lentz V. IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. J Immunol 1990; 145: 161–166.
- 12 Snyers L et al. Glucocorticoid up-regulation of high-affinity interleukin 6 receptors on human epithelial cells. Proc Natl Acad Sci U S A 1990; 87: 2838–2842.
- 13 Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 2004; 18: 2195–2224.
- 14 Sun SC et al. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 1993; 259: 1912–1915.
- 15 Chiao PJ et al. Autoregulation of I kappa B alpha activity. Proc Natl Acad Sci U S A 1994; 91: 28–32.
- 16 Auphan N et al. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995; 270: 286–290.
- 17 Schacke H et al. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index. Mol Cell Endocrinol 2007; 275: 109–117.
- 18 Rhoades KL et al. The regulation of the human tumor necrosis factor alpha promoter region in macrophage, T cell, and B cell lines. J Biol Chem 1992; 267: 22102–22107.
- 19 Gaestel M et al. Targeting innate immunity protein kinase signalling in inflammation. Nat Rev Drug Discov 2009; 8: 480–499.
- 20 Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001; 13: 85–94.
- 21 Dower SK, Qwarnstrom EE. Signalling networks, inflammation and innate immunity. Biochem Soc Trans 2003; 31: 1462–1471.
- 22 Swinney DC et al. A small molecule ubiquitination inhibitor blocks NF-kappa B-dependent cytokine expression in cells and rats. J Biol Chem 2002; 277: 23573–23581.
- 23 Hess J et al. AP-1 subunits: quarrel and harmony among siblings. J Cell Sci 2004; 117: 5965–5973.
- 24 Joyce DA et al. Targets of glucocorticoid action on TNF-alpha release by macrophages. Inflamm Res 2001; 50: 337–340.
- 25 Sironi M et al. Differential sensitivity of in vivo TNF and IL-6 production to modulation by anti-inflammatory drugs in mice. Int J Immunopharmacol 1992; 14: 1045–1050.
- 26 Barber AE et al. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 1993; 150: 1999–2006.
- 27 Choy EH et al. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum 2002; 46: 3143–3150.
- 28 Ito H et al. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 2004; 126: 989–996.
- 29 Tilg H et al. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994; 83: 113–118.
- 30 Zhou Xing JG et al. IL-6 is an inflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101: 311–320.
- 31 Beverly E. Barton JVJ. Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model. Infect Immun 1993; 61: 1496–1499.
- 32 Dan Aderka JL, Jan Vilcek. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 1989; 143: 3517–3523.
- 33 Kim K et al. MEKK3 is essential for lipopolysaccharide-induced interleukin-6 and granulocyte-macrophage colony-stimulating factor production in macrophages. Immunology 2007; 120: 242–250.
- 34 Lee IK et al. Phytochemical constituents of Schizonepeta tenuifolia Briquet. Natural Product Sciences 2008; 14: 100–106.
- 35 Ikeda Y et al. Ursolic acid: an anti- and pro-inflammatory triterpenoid. Mol Nutr Food Res 2008; 52: 26–42.
- 36 Xagorari A et al. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J Pharmacol Exp Ther 2001; 296: 181–187.
- 37 Xagorari A et al. Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin. Br J Pharmacol 2002; 136: 1058–1064.
- 38 Kotanidou A et al. Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice. Am J Respir Crit Care Med 2002; 165: 818–823.
- 39 Yeh CC et al. The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro. Life Sci 2007; 80: 1821–1831.
- 40 Li R et al. Suppression of adjuvant arthritis by hesperidin in rats and its mechanisms. J Pharm Pharmacol 2008; 60: 221–228.
- 41 Osakabe N et al. Rosmarinic acid inhibits epidermal inflammatory responses: anticarcinogenic effect of Perilla frutescens extract in the murine two-stage skin model. Carcinogenesis 2004; 25: 549–557.
- 42 Lee J et al. R osmarinic acid as a downstream inhibitor of IKK-beta in TNF-alpha-induced upregulation of CCL11 and CCR3. Br J Pharmacol 2006; 148: 366–375.
- 43 Lee J et al. Effect of rosmarinic acid on atopic dermatitis. J Dermatol 2008; 35: 768–771.
- 44 Kim HK et al. Rosmarinic acid down-regulates the LPS-induced production of monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha (MIP-1alpha) via the MAPK pathway in bone-marrow derived dendritic cells. Mol Cells 2008; 26: 583–589.